2026 National Conference on Cell Storage and Future Health Development
2026 National Conference on Cell Storage and Future Health Development
Concurrent Event: 2026 China Cell Industry & Genetic Diagnosis and Treatment Technology Application Expo
Conference Highlights:
With the rapid development of life science technology, cell storage and application, represented by stem cells and immune cells, have become a new blue ocean for safeguarding future human health and fighting major diseases. To discuss the standardized construction and industrial implementation of cell storage technology, and to jointly build the "Healthy China 2030" strategy, the organizing committee has decided to hold the "2026 National Conference on Cell Storage and Future Health Development" from November 5-7, 2026 at the Guangzhou Health Ark Conference and Exhibition Center. The 2026 China Cell Industry & Genetic Diagnosis and Treatment Technology Application Expo will be held concurrently.
I. Conference Theme
Storing the Seeds of Life, Safeguarding Future Health
II. Conference Time and Location
Exhibition Dates: November 5-7, 2026
Exhibition Venue: Guangzhou Health Ark Conference and Exhibition Center
Organizing Committee Secretariat:
Mobile/WeChat: 15889977720 Shu Rong
Email: zhishenzhanlan@163.com
III. Organizational Structure
Host Unit:
Guangdong Integrated Life Health Technology Center
Co-organizers:
National Cell Storage Industry Alliance
Stem Cell and Regenerative Medicine Working Committee of China Food and Drug Safety Promotion Association
Guangdong Biomedical Industry High-Quality Development Association
Guangzhou Bio-industry Alliance
Organizers:
Guangzhou Chuangmai Exhibition Planning Co., Ltd.
Guangzhou Zhishen Exhibition Co., Ltd.
Exhibition Scope:
1. Cell storage institutions, cell banks (stem cell banks, biobanks), umbilical cord blood hematopoietic stem cell banks;
2. Cell storage equipment, cryopreservation bags, liquid nitrogen tanks, controlled rate freezers, centrifuges, microscopes, testing instruments;
3. Cell biosafety cabinets, carbon dioxide incubators, ultra-low temperature water baths, cell counters, pure water equipment;
4. Flow cytometers, automated cell processors, pipettes and sterile consumables;
5. Data management systems, intelligent cell real-time monitoring systems;
6. Health checkup institutions, physical examination instruments and equipment, health screening diagnostic instruments and test reagents;
V. Core Highlights
· Authoritative Release: Release of the "White Paper on China's Cell Storage Industry (2026 Edition)".
· Top-level Dialogue: Academician Forum, Roundtable Meeting of Presidents from Grade 3A Hospitals.
· Field Visit: Tour of internationally leading GMP standard laboratories and biobanks.
VII. Invited Participants
Cell banks, life science researchers, maternal and child hospitals, healthcare medical institutions, biological cell enterprises, health management centers, anti-aging centers, elderly care, medical aesthetics, high-net-worth individuals, people planning for childbirth, banking and insurance institutions, representatives of investment institutions, etc.
Professional Visitors Invited From:
1. Persons in charge of Health Commissions of provinces and cities nationwide, medical experts, health research units, medical inspection laboratories, medical colleges, research institutions, biomedicine, cross-border medical care, etc.;
2. Presidents and hospital managers of hospitals in various provinces and cities nationwide, physicians and experts in related research fields from departments such as Oncology, Biotherapy, Hematology, Pathology, Assisted Reproduction, Clinical Laboratory, etc.;
3. Professors and researchers from renowned universities, pharmacy majors, medical majors, immunology, and enterprises in the upstream, midstream, and downstream of the biomedicine industry;
4. CEOs of innovative drugs and heads of R&D in pharmaceutical companies: CRO, CMO, antibody immunotherapy drug R&D, immune cell therapy and product development, oncolytic viruses, small molecule immunotherapy drugs, experts in the field of cell therapy and regenerative medicine
5. Upstream and downstream enterprises of the cell industry;
6. Government agencies and representatives, industrial parks, investment promotion bureaus, investment incubation institutions, consulting and training institutions, wealth inheritance, private banks, lawyers, intellectual property, securities companies, etc.
7. Nursing homes, rehabilitation centers, wellness institutions, beauty salons, TCM clinics, wellness centers, tourism, hospitals, agents, distributors, brand owners, channel distributors, maternal and child health hospitals, medical institutions, pharmacies, community health service centers, pharmaceutical chain supermarkets, import and export traders, rehabilitation centers, nursing centers, high-end medical service institutions, foreign agencies in China, foreign sales agencies in China, blood stations, CDCs, laboratories, medical colleges, medical and health institutions, rehabilitation nursing centers, maternal and child health hospitals, high-end medical service institutions, pharmacies, pharmaceutical chain supermarkets, blood stations, CDCs, research units, colleges, banking and insurance industry, and other professional visitors.
